within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01X_OtherAntineoplasticAgents.L01XG01_Bortezomib;

model Bortezomib
  extends Pharmacolibrary.Drugs.ATC.L.L01XG01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>name:</td><td>Bortezomib</td></tr><tr><td>ATC code:</td><td>L01XG01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>3</td></tr></table><p>Bortezomib is a reversible proteasome inhibitor used primarily in the treatment of multiple myeloma and mantle cell lymphoma. It is administered parenterally and is FDA-approved for clinical use.</p><h4>Pharmacokinetics</h4><p>Healthy adult patients and patients with multiple myeloma, intravenous bolus administration.</p><h4>References</h4><ol><li><p>Savelieva, M, et al., &amp; Capdeville, R (2015). Population pharmacokinetics of intravenous and oral panobinostat in patients with hematologic and solid tumors. <i>European journal of clinical pharmacology</i> 71(6) 663–672. DOI:<a href=\"https://doi.org/10.1007/s00228-015-1846-7\">10.1007/s00228-015-1846-7</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25939707/\">https://pubmed.ncbi.nlm.nih.gov/25939707</a></p></li><li><p>Hanley, MJ, et al., &amp; Venkatakrishnan, K (2017). Population Pharmacokinetic Analysis of Bortezomib in Pediatric Leukemia Patients: Model-Based Support for Body Surface Area-Based Dosing Over the 2- to 16-Year Age Range. <i>Journal of clinical pharmacology</i> 57(9) 1183–1193. DOI:<a href=\"https://doi.org/10.1002/jcph.906\">10.1002/jcph.906</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28419486/\">https://pubmed.ncbi.nlm.nih.gov/28419486</a></p></li><li><p>Janssen, JM, et al., &amp; Huitema, ADR (2020). A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia. <i>Clinical pharmacokinetics</i> 59(2) 207–216. DOI:<a href=\"https://doi.org/10.1007/s40262-019-00803-y\">10.1007/s40262-019-00803-y</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31313068/\">https://pubmed.ncbi.nlm.nih.gov/31313068</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Bortezomib;
